See also this year's filing and all EDGAR filings for this company.
PDF Report 0001716947_2026_Ensysce_Biosciences_Inc.pdf
Logs
Graph
Absolute values for 0001716947, Ensysce Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,242,468 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 124,129 |
| 3 | remainder_Assets | 85,882 |
| 4 | LiabilitiesCurrent | 4,567,729 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 4,868,962 |
| 9 | ResearchAndDevelopmentExpense | 9,691,372 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 5,090,881 |
| 12 | remainder_NetIncome | -390,637 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,452,479 |
| 1 | Liabilities | 4,567,729 |
| 2 | Expenses | 14,560,334 |
| 3 | Revenues | 5,090,881 |
| 4 | StockholdersEquity | 2,884,750 |
| 5 | NetIncome | -9,860,090 |
| 6 | ComprehensiveNetIncome | -9,860,090 |
| 7 | BaseVar | 16,031,030 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.594 |
| 9 | EconomicCapitalRatio | 1.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
